229 related articles for article (PubMed ID: 17086606)
1. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.
Ballok DA; Ma X; Denburg JA; Arsenault L; Sakic B
J Rheumatol; 2006 Nov; 33(11):2199-213. PubMed ID: 17086606
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
Ballok DA; Millward JM; Sakic B
Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
[TBL] [Abstract][Full Text] [Related]
5. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
6. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway.
Lu L; Wang H; Liu X; Tan L; Qiao X; Ni J; Sun Y; Liang J; Hou Y; Dou H
J Neuroinflammation; 2021 Oct; 18(1):229. PubMed ID: 34645459
[TBL] [Abstract][Full Text] [Related]
9. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
Front Immunol; 2020; 11():573677. PubMed ID: 33042154
[TBL] [Abstract][Full Text] [Related]
10. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
[TBL] [Abstract][Full Text] [Related]
11. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA
J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826
[TBL] [Abstract][Full Text] [Related]
13. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
14. Disturbed distribution of proliferative brain cells during lupus-like disease.
Stanojcic M; Burstyn-Cohen T; Nashi N; Lemke G; Sakic B
Brain Behav Immun; 2009 Oct; 23(7):1003-13. PubMed ID: 19501646
[TBL] [Abstract][Full Text] [Related]
15. Ectopic CD4
Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
[TBL] [Abstract][Full Text] [Related]
16. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
Williams S; Sakic B; Hoffman SA
J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
Huang MW; Stock AD; Putterman C
Front Immunol; 2021; 12():763065. PubMed ID: 34868008
[TBL] [Abstract][Full Text] [Related]
18. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal antibodies and brain damage in autoimmune MRL mice.
Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
[TBL] [Abstract][Full Text] [Related]
20. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]